- Home
- CNTX vs UBXG Comparison
CNTX vs UBXG Comparison
Compare CNTX & UBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTX
- UBXG
- Stock Information
- Founded
- CNTX 2015
- UBXG 2018
- Country
- CNTX United States
- UBXG China
- Employees
- CNTX N/A
- UBXG N/A
- Industry
- CNTX Biotechnology: Pharmaceutical Preparations
- UBXG
- Sector
- CNTX Health Care
- UBXG
- Exchange
- CNTX Nasdaq
- UBXG Nasdaq
- Market Cap
- CNTX 75.6M
- UBXG 67.8M
- IPO Year
- CNTX 2021
- UBXG 2024
- Fundamental
- Price
- CNTX $0.82
- UBXG $2.93
- Analyst Decision
- CNTX Strong Buy
- UBXG
- Analyst Count
- CNTX 5
- UBXG 0
- Target Price
- CNTX $5.25
- UBXG N/A
- AVG Volume (30 Days)
- CNTX 162.2K
- UBXG 257.3K
- Earning Date
- CNTX 11-05-2025
- UBXG 01-01-0001
- Dividend Yield
- CNTX N/A
- UBXG N/A
- EPS Growth
- CNTX N/A
- UBXG N/A
- EPS
- CNTX N/A
- UBXG N/A
- Revenue
- CNTX N/A
- UBXG $39,603,353.00
- Revenue This Year
- CNTX N/A
- UBXG N/A
- Revenue Next Year
- CNTX N/A
- UBXG N/A
- P/E Ratio
- CNTX N/A
- UBXG N/A
- Revenue Growth
- CNTX N/A
- UBXG N/A
- 52 Week Low
- CNTX $0.49
- UBXG $2.36
- 52 Week High
- CNTX $2.59
- UBXG $19.20
- Technical
- Relative Strength Index (RSI)
- CNTX 52.03
- UBXG 48.05
- Support Level
- CNTX $0.81
- UBXG $2.50
- Resistance Level
- CNTX $0.94
- UBXG $3.10
- Average True Range (ATR)
- CNTX 0.05
- UBXG 0.50
- MACD
- CNTX -0.01
- UBXG -0.04
- Stochastic Oscillator
- CNTX 10.36
- UBXG 26.07
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
About UBXG U-BX Technology Ltd. Ordinary Shares
U-BX Technology Ltd is focused on providing value-added services using artificial intelligence-driven technology to businesses within the insurance industry, including insurance carriers and brokers. It helps institutional clients obtain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or its clients' promotion time through those channels. The company derives a majority of its revenue by providing digital promotion services to its clients and also engages in providing risk assessment services, and value-added bundled benefits. It has developed an algorithm named Magic Mirror, to calculate payout risks for insurance carriers to underwrite auto insurance coverage. Geographically, all of the company's revenue is derived from Mainland China.